Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5V60
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,058
Award facts
- Contract value 100% obligated
- $31,057.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,057.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflecting the Defense Logistics Agency Medical Supply Chain's procurement of critical pharmaceutical commodities for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse therapeutic domains including specialty medications, generic drugs, and medical supplies. The contract vehicle supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a key provider within the Department of Defense's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F5V60?
SPE2DR26F5V60 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F5V60 worth?
The government has obligated $31,058 on SPE2DR26F5V60.
Is contract SPE2DR26F5V60 an order under another contract?
Yes. SPE2DR26F5V60 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5V60 competed?
The extent of competition for SPE2DR26F5V60 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award